Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000850693-13-000006
Filing Date
2013-08-07
Accepted
2013-08-07 17:01:49
Documents
14
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q agn10-qq22013.htm 10-Q 2005240
2 EXHIBIT 10.1 agnex10120130630.htm EX-10.1 27455
3 EXHIBIT 10.2 agnex10220130630.htm EX-10.2 63709
4 EXHIBIT 31.1 agnex31120130630.htm EX-31.1 12093
5 EXHIBIT 31.2 agnex31220130630.htm EX-31.2 12506
6 EXHIBIT 32 agnex3220130630.htm EX-32 12605
13 agnimage.jpg GRAPHIC 23620
14 agnlogo.jpg GRAPHIC 5233
  Complete submission text file 0000850693-13-000006.txt   15625033

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT agn-20130630.xml EX-101.INS 1926028
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT agn-20130630.xsd EX-101.SCH 57237
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT agn-20130630_cal.xml EX-101.CAL 104246
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT agn-20130630_def.xml EX-101.DEF 223132
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT agn-20130630_lab.xml EX-101.LAB 772922
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT agn-20130630_pre.xml EX-101.PRE 396773
Mailing Address P.O. BOX 19534 IRVINE CA 92713-9534
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142464500
ALLERGAN INC (Filer) CIK: 0000850693 (see all company filings)

EIN.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10269 | Film No.: 131018789
SIC: 2834 Pharmaceutical Preparations